Dr. Arie Gutman, Ph.D.

Overview

Dr. Gutman has served as a Director since February 7, 2008. In 1991, Dr. Gutman founded FineTech Laboratories Ltd, and served as its Chief Executive Officer and President. He continues to serve as President of our FineTech Pharmaceutical Ltd. subsidiary. In 2001, FineTech merged with International Specialty Products ("ISP"), and Dr. Gutman was appointed President and Chief Executive Officer of ISP-FineTech. In 2002, ISP-FineTech was acquired by Par Pharmaceutical and Dr. Gutman was appointed a Director of Par. In 2006, FineTech was divested from Par and Dr. Gutman again became the sole Owner of FineTech. In connection with the FineTech Acquisition in January 2008, Dr. Gutman was appointed President of FineTech Pharmaceutical. Dr. Gutman has been a visiting Professor at various universities in the United States, the United Kingdom, Germany and Japan and has a Ph.D from Cambridge University. On August 19, 2008, Dr. Arie Gutman resigned from the board of directors.